3D Bioprinting Engineers create cutting-edge technologies that layer living cells and biomaterials to build three-dimensional biological structures. They focus on creating bioinks that maintain cell viability and support the mechanical properties needed for the printed constructs to hold shape and function. By integrating principles of mechanical engineering, materials science, and cell biology, they build printers and software that can fabricate intricate, tissue-like architectures. Their work enables the production of personalized biological models for applications in research, drug testing, and therapeutic development.
Beyond printer and bioink formulation, 3D Bioprinting Engineers collaborate with interdisciplinary teams to address challenges like nutrient delivery, vascularization, and structural integrity of the constructs. They optimize printing protocols to improve cell survival and ensure the mechanical stability of the printed tissues. Their contributions accelerate the development of customized medical treatments and innovative therapeutic options. Their expertise is vital for advancing biofabrication technologies. By combining engineering innovation with biological systems, they unlock new possibilities in healthcare. They are driving progress toward the development of cutting-edge regenerative therapies and experimental tools. They continuously explore new materials and methods to enhance print resolution and tissue complexity. Their work supports the creation of more reliable and scalable biofabrication platforms. Through ongoing innovation, they drive progress toward practical clinical applications.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States